Status: Recruiting
A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)
This is an exploratory, randomized, double-blind, multicentre, placebo-controlled study of RTP-026. The study population will consist of men and women with documented evidence of ST-elevation myocardial infarction (STEMI) referred to primary Percutaneous Coronary Intervention (PCI).
Participants needed: 96
Trial details
Phase: Phase 2Age: 18-85Biological sex: AllType: InterventionalSponsor: ResoTher PharmaUpdated: Sep 22, 2025Locations: 1
Eligibility criteria
Informed consent for participation in the study has been obtained prior to initi... [+5]
Participation in any other study involving investigational drug(s) during the st... [+8]